The Effect of Semax and Its C-End Peptide PGP on the Morphology and Proliferative Activity of Rat Brain Cells During Experimental Ischemia: A Pilot Study
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The neuropeptide preparation Semax (Met-Glu-His-Phe-Pro-Gly-Pro) has been employed successfully in clinical practice for treating patients with severe brain blood circulation disorders. In spite of numerous studies, many aspects of the therapeutic effects of this preparation remain unknown. In this context, the effects of Semax and its C-end tripeptide PGP on the functional morphology of nervous tissue cells were studied in the normal rat brain and in a model of incomplete global rat brain ischemia. In control animals, both peptides activated the capillary network and caused similar morphological changes to neurons and the neuropil regions. We show here for the first time at the histological level that Semax and PGP increased proliferation of the neuroglia, blood vessel endothelium, and progenitor cells in the subventricular zone. In these experimental conditions, only Semax abated the manifestation of ischemic damage to the nervous tissue. This was probably attributable to a decrease in vascular stasis symptoms as well as the trophic effect of the peptide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it enhances the transcription of neurotrophins and their receptors [13,14]”
From Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion (2021) · cites this paper as [14]
In the citing paper
“Previously, using models of global incomplete cerebral ischaemia we have shown the effect of Semax on the expression of the limited number of genes that encode neurotrophic factors and their receptors [23,24,25].”
From Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats (2020) · cites this paper as [25]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · cited 1×
“Morphological analysis was conducted with allowance for normal and pathological CNS variants (Garcia et al. 1995; Li et al. 1998; Lipton 1999).”
MethodAdult neurogenesis: from precursors to network and physiology
Abrous, D. N., Koehl, M., & Le Moal, M. (2005) · Physiological Reviews · doi:10.1152/physrev.00055.2003 · Cited by 971
Neuroprotection for ischemic stroke: Two decades of success and failure
Cheng, Y. D., Al-Khoury, L., & Zivin, J. A. (2004) · NeuroRX · doi:10.1602/neurorx.1.1.36 · Cited by 384
Garcia, J. H., Liu, K.-F., & Ho, K.-L. (1995) · Stroke · doi:10.1161/01.str.26.4.636 · Cited by 361
Ginsberg, M. D. (2003) · Stroke · doi:10.1161/01.str.0000048846.09677.62 · Cited by 264
Intact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat
Li, Y., Powers, C., Jiang, N., & Chopp, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00036-7 · Cited by 187
Yakovlev, A. G., & Faden, A. I. (2004) · Neurotherapeutics · doi:10.1602/neurorx.1.1.5 · Cited by 186
Chen, X., Iwata, A., Nonaka, M., Browne, K. D., & Smith, D. H. (2003) · Journal of Neurotrauma · doi:10.1089/089771503322144545 · Cited by 113
Mechanisms of Cerebral Ischemic Damage
Iadecola, C. (1999) · Cerebral Ischemia · doi:10.1007/978-1-59259-479-5_1 · Cited by 57
Dmitrieva, V. G., Povarova, O. V., Skvortsova, V. I., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9432-0 · Cited by 54 · cited 1×
“Thus, Semax stimulates the transcription of mRNA for neurotrophins and their receptors in the CNS of animals subjected to experimental ischemia ( Dmitrieva et al. 2010 ).”
BackgroundSelf-citationShadrina, M. I., Dolotov, O. V., Grivennikov, I. A., Slominsky, P. A., Andreeva, L. A., Inozemtseva, L. S., Limborska, S. A., & Myasoedov, N. F. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01994-2 · Cited by 46
Self-citationCEREBRAL ISCHEMIA: MOLECULAR AND CELLULAR PATHOPHYSIOLOGY.
Cox, D. P. M. (2000) · Brain · doi:10.1093/brain/123.4.847 · Cited by 45
Faiz, M., Acarín, L., Castellano, B., & González, B. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-26 · Cited by 43
Storozhevykh, T. P., Tukhbatova, G. R., Senilova, Y. E., Pinelis, V. G., Andreeva, L. A., & Myasoyedov, N. F. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0192-x · Cited by 41 · cited 1×
“2009) and glutamate toxicity (Storozhevykh et al. 2007).”
New Vistas for Melanocortins: Finally, an Explanation for Their Pleiotropic Functions
STRAND, F. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07874.x · Cited by 39
Cerebral ischemia : molecular and cellular pathophysiology
Walz, W. (1999) · Humana Press eBooks · Cited by 36
Bashkatova, V. G., Koshelev, V. B., Fadyukova, O. E., Alexeev, A. A., Vanin, A. F., Rayevsky, K. S., Ashmarin, I. P., & Armstrong, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03324-2 · Cited by 36 · cited 1×
“Immunomodulation, deceleration of inflammatory responses, slowing the synthesis of nitrogen oxide, and limiting oxidative stress reactions are its main manifestations (Astashkin et al. 2000; Bashkatova et al. 2001).”
BackgroundCell-Specific Upregulation of Survivin after Experimental Traumatic Brain Injury in Rats
Johnson, E. A., Svetlov, S. I., Pike, B. R., Tolentino, P. J., Shaw, G., Wang, K., Hayes, R. L., & Pineda, J. (2004) · Journal of Neurotrauma · doi:10.1089/neu.2004.21.1183 · Cited by 35
The Heptapeptide SEMAX stimulates BDNF Expression in Different Areas of the Rat Brain in vivo
Dolotov, O. V., Seredenina, T. S., Levitskaya, N. G., Kamensky, A. A., Андреева, Л. А., Alfeeva, L. Y., Nagaev, I. Y., Zolotarev, Y. A., Grivennikov, I. A., Engele, Y., et al. (2003) · Doklady Biological Sciences · doi:10.1023/a:1025177812262 · Cited by 20
Self-citationMartynova, K. V., Андреева, Л. А., Климова, П. А., Kirillova, Y. G., Shevchenko, V. P., Nagaev, I. Y., Shram, S. I., Швец, В. И., & Myasoedov, N. F. (2009) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162009020022 · Cited by 19
Self-citationDmitrieva, V. G., Dergunova, L. V., Поварова, О. В., Skvortsova, V. I., Limborskaya, S. A., & Myasoedov, N. F. (2008) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672908050037 · Cited by 16
Self-citationGrivennikov, I. A., Dolotov, O. V., Zolotarev, Y. A., Andreeva, L. A., Myasoedov, N. F., Leacher, L., Black, I. B., & Dreyfus, C. F. (2008) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2008-00419 · Cited by 14 · cited 1×
“According to the literature, Semax has neuroprotective effects (Levitskaya et al. 2004; Grivennikov et al. 2008).”
BackgroundSelf-citationEvaluation of therapeutic effect of new Russian drug semax in optic nerve disease
Polunin, G. S., Nurieva, S. M., Baiandin, D. L., & Sheremet, N. L. (2000) · PubMed · Cited by 13
Gusev, E. I., Skvortsova, V. I., & Chukanova, E. I. (2005) · PubMed · Cited by 12
Self-citationLevitskaya, N. G., Sebentsova, E. A., Андреева, Л. А., Alfeeva, L. Y., Каменский, А. А., & Myasoedov, N. F. (2004) · Neuroscience and Behavioral Physiology · doi:10.1023/b:neab.0000018752.59465.28 · Cited by 11
Self-citationTsyb, A. F., Yuzhakov, V. V., Roshal, L. M., Sukhikh, G. T., Konoplyannikov, A. G., Сушкевич, Г. Н., Yakovleva, N. D., Ингель, И. Э., Бандурко, Л. Н., Sevan’kaeva, L. E., et al. (2009) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-009-0432-3 · Cited by 10
Self-citationCherkasova, K. A., Lyapina, L. A., & Ашмарин, И. П. (2001) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1012503606536 · Cited by 8
Umriukhin, P. E., Koplik, E. V., Grivennikov, I. A., et al. (2002) · PubMed · Cited by 8
In vivo efficiency of Semax in global cerebral ischemia
Yakovleva, E. V., Кузенков, В. С., Федоров, В. Н., Skvortsova, V. I., Кошелев, В. Б., Gusev, E. I., & Ашмарин, И. П. (1999) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf02433821 · Cited by 8
Self-citation[Study of the efficacy of semax in global cerebral ischemia in vivo].
Iakovleva, E. V., Кузенков, В. С., Федоров, В. Н., Skvortsova, V. I., Кошелев, В. Б., Gusev, E. I., & Ашмарин, И. П. (1999) · PubMed · Cited by 6
Self-citationEffects of Semax on Ca2+ responses of human neutrophils.
Astashkin, E. I., YuB, B., Grivennikov, I. A., Smirnov, O. N., Глезер, М. Г., Sv, G., & Nf, M. (2000) · PubMed · Cited by 5
(1996) · doi:10.1002/(sici)1520-6769(199609)19:2<115::aid-nrc171>3.0.co;2-b
Research works printed but not linked: 1
- Gusev Eu I, Skvortsova VI (2001) Brain ischaemia. Meditsina, Moscow, pp 249–276
Cited by
Giuliani, D., Ottani, A., Neri, L., Zaffe, D., Grieco, P., Jochem, J., Cavallini, G. M., Catania, A., & Guarini, S. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.004 · Cited by 38
Melanocortins as potential therapeutic agents in severe hypoxic conditions
Giuliani, D., Minutoli, L., Ottani, A., Spaccapelo, L., Bitto, A., Galantucci, M., Altavilla, D., Squadrito, F., & Guarini, S. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.04.001 · Cited by 35
Medvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborska, S. A., Skvortsova, V. I., Myasoedov, N. F., & Dergunova, L. V. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-228 · Cited by 33
Self-citationNeuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries
Dergunova, L. V., Filippenkov, I. B., Limborska, S. A., & Myasoedov, N. F. (2023) · Genes · doi:10.3390/genes14050953 · Cited by 40
Self-citationA New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30
“Judging by the upregulation of PCNA in the nuclei of the brain cells of control animals, Semax appears to stimulate the proliferation of repopulating elements of the nervous tissue [73].”
Self-citation
Metadata
- Authors
- Stavchansky, V. V., Yuzhakov, V. V., Botsina, A. Y., Skvortsova, V. I., Bondurko, L. N., Tsyganova, M. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V.
- Affiliations
- Russian Academy of Sciences (RU)
- Medical Radiological Research Center (RU)
- Pirogov Russian National Research Medical University (RU)
- Corresponding author
- Stavchansky, Vasily V.
- ORCID
- Venue
- Journal of Molecular Neuroscience
- Published
- 2010-07-09
- Volume
- 45
- Issue
- 2
- Pages
- 177-185
- ISSN
- 0895-8696 (ISSN-L)
- 1559-1166
- OpenAlex
- W2021663492
- Cited by
- 34
- References
- 33
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2017: 4 · 2016: 6 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Russian Foundation for Basic Research
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Semax, neuropeptides, cerebral ischemia, neuroprotection, endothelial cell proliferation, neuronal morphology, capillary network, vascular stasis, ischemic injury
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Brain, Brain Ischemia, Humans, Male, Oligopeptides, Peptide Fragments, Pilot Projects, Proline, Rats, Wistar, Neuroprotective Agents, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.